Ontology highlight
ABSTRACT:
SUBMITTER: Wang J
PROVIDER: S-EPMC4265673 | biostudies-literature | 2014 Dec
REPOSITORIES: biostudies-literature
Wang Jiadong J Aroumougame Asaithamby A Lobrich Markus M Li Yujing Y Chen David D Chen Junjie J Gong Zihua Z
Genes & development 20141201 24
PARP inhibitors (PARPis) are being used in patients with BRCA1/2 mutations. However, doubly deficient BRCA1(-/-)53BP1(-/-) cells or tumors become resistant to PARPis. Since 53BP1 or its known downstream effectors, PTIP and RIF1 (RAP1-interacting factor 1 homolog), lack enzymatic activities directly implicated in DNA repair, we decided to further explore the 53BP1-dependent pathway. In this study, we uncovered a nuclease, Artemis, as a PTIP-binding protein. Loss of Artemis restores PARPi resistan ...[more]